Companies / Idexx Laboratories Inc /De

Idexx Laboratories Inc /De

Nasdaq: IDXXCIK 874716Health CareWESTBROOK, MEidexx.com ↗

Financials · FY2025

Revenue$4.30B
Net income$1.06B
Total debt$299.87M
Cash$196.93M
Diluted EPS$13.08
Shares outstanding78.8M

Ownership

78.8M shares outstanding · as of Jul 31, 2026
0.21%Insiders
Ownership
Insiders0.21%169,111
Institutions100.71%79,343,604
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 16

View all →
Insider% of sharesShares
Mazelsky Jonathan JayCEOPresident and CEO · Director
0.11%83,803
Hunt NimrataExecutive Vice President
0.02%18,141
Erickson Michael GExecutive Vice President
0.02%15,092
Fennell GeorgeExecutive Vice President
0.01%10,078
Kingsley Lawrence DDirector
0.01%9,568
Lane MichaelExecutive Vice President
0.01%8,024
Underberg Sharon E.EVP, GC & Corporate Secretary
<0.01%7,138
Emerson AndrewEVP, CFO and Treasurer
<0.01%4,222
Junius Daniel MDirector
<0.01%3,561
Schreck MichaelExecutive Vice President
<0.01%3,089

Institutional holders 1,383

View all →
HolderValue% of shares
Vanguard Group Inc$6.73B12.62%
BlackRock, Inc.$4.30B10.37%
State Street Corporation$1.97B4.76%
Geode Capital Management, LLC$1.50B3.38%
Fundsmith LLP$1.27B2.38%
Morgan Stanley$1.05B1.97%
Invesco Ltd.$1.02B1.91%
Bamco Inc /Ny$917.77M2.07%
Bank of New York Mellon Corp/The$845.38M1.91%
Blair William & CO/IL$677.46M1.27%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 26, 2026Mazelsky Jonathan Jay
CEO
ExerciseCommon Stock$3.30M+23K
+27.90%
106,932
0.14% of shares
low
Feb 26, 2026Mazelsky Jonathan Jay
CEO
SellCommon Stock$2.41M-4K
-3.86%
91,254
0.12% of shares
medium
Feb 26, 2026Mazelsky Jonathan Jay
CEO
SellCommon Stock$1.89M-3K
-3.13%
88,395
0.11% of shares
medium
Feb 26, 2026Mazelsky Jonathan Jay
CEO
SellCommon Stock$1.88M-3K
-2.93%
94,914
0.12% of shares
medium
Feb 10, 2026Fennell George
Executive
SellCommon Stock$1.82M-3K
-22.17%
9,863
0.01% of shares
medium
Feb 10, 2026Fennell George
Executive
SellCommon Stock$1.80M-3K
-15.92%
14,698
0.02% of shares
medium
Feb 26, 2026Hunt Nimrata
Executive
SellCommon Stock$1.78M-3K
-11.92%
19,899
0.03% of shares
medium
Feb 26, 2026Mazelsky Jonathan Jay
CEO
SellCommon Stock$1.72M-3K
-3.00%
83,606
0.11% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
IDXX——45168D104—